The lifesite hemodialysis access system in patients with limited access

Journal of Vascular Surgery

Volumn 38, Issue 4, 2003, Pages 714-718

  Rayan, Sunil S ^b   Terramani, Thomas T ^b   Weiss, Victor J ^b   Chaikof, Elliot L ^a  

^a EMORY UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERIOVENOUS FISTULA; BLOOD VESSEL GRAFT; CATHETER; CATHETER INFECTION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DEVICE; FEMALE; GRAFT PATENCY; HEMODIALYSIS; HUMAN; MALE; PATIENT SATISFACTION; PERFORMANCE; PRIORITY JOURNAL; SURVIVAL; TREATMENT FAILURE; VASCULAR ACCESS;

EID: 0141954239     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)00793-6     Document Type: Conference Paper

References (14)

1. Mayers JD, Markell MS, Cohen LS, Hong J, Lundin P, Friedman EA. Vascular access surgery for maintenance hemodialysis: variables in hospital stay. ASAIO J 1992;38:113-5.
2. Schwab SJ, Beathard G. The hemodialysis catheter conundrum: hate living with them, but can't live without them. Kidney Int 1999;56:1-17.
3. Moran JE. Subcutaneous vascular access devices. Semin Dial 2001;14:452-7.
4. Beathard GA, Posen GA. Initial clinical results with the LifeSite hemodialysis access system. Kidney Int 2000;58:2221-7.
5. Lamarche MB, Zeik JC, Clark RV. High performance and low complication rates of a subcutaneous vascular access device: the LifeSite hemodialysis access system. Dial Transplant 2002;31:799-806.
6. Schwab SJ, Weiss MA, Rushton F, Ross JP, Jackson J, Kapoian T, et al. Multicenter clinical trial results with the LifeSite hemodialysis access system. Kidney Int 2002;62:1026-33.
7. Ross JJ, Narayan G, Bergeron EK, Worthington MG, Strom JA. Infections associated with use of the LifeSite Hemodialysis Access System. Clin Infect Dis 2002;35:93-5.
8. Ross JR. Clinical outcomes of four hemodialysis patients implanted with the LifeSite® Hemodialysis Access System: a novel approach for vascular access. In: Henry ML, editor. Vascular access for hemodialysis-VII. Chicago: W.L. Gore and Precept Press; 2001. p. 109-121.
9. Saad TF. Central venous dialysis catheters: catheter-associated infection. Semin Dial 2001;14:446-51.
10. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 2000;58:2543-5.
11. Almirall J, Gonzalez J, Rello J, Campistol JM, Montoliu J, Puig de la Bellacasa J, et al. Infection of hemodialysis catheters: incidence and mechanisms. Am J Nephrol 1989;9:454-9.
12. NKF-K/DOQI. Clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis 2001;37(Suppl 1):S137-81.
13. Department of Health and Human Services, US Food and Drug Administration. Warning Letter 2001. Number NWE-04-02W. Available from: URL:http://www.fda.gov/foi/warning_letters/g2045d.pdf.
14. Ross J. Subcutaneous implantation of the LifeSite hemodialysis access system in the femoral vein. J Vasc Access 2001;2:91-6.